Meeting
2021 Gastrointestinal Cancers Symposium
The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).
Authors
Estephany Abou Jokh Casas
Nuclear Medicine Deparment-Hospital Clinico Universitario de Santiago de Compostela, Santiago De Compostela, Spain
Estephany Abou Jokh Casas , Nieves Martinez Lago , Jose Manuel Cabezas Agricola , Urbano Anido Herranz , Francisco Baron , Ovidio Fernandez Calvo , Maria Quindós Varela , Silvia Varela Ferreiro , Alberto Carral Maseda , Jose Maria De Matias Leralta , Zulema Nogareda Seoane , Antia Cousillas Castiñeira , Sofia Rodriguez Martinez de LLano , Jose Antonio Mato Mato , Pablo Fernández Catalina , Omar Rodriguez Fonseca , Gloria Muñiz Garcia , Beatriz Bernardez , Jose Manuel Cameselle Teijeiro , Virginia Pubul Nuñez
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Neuroendocrine/Carcinoid
Track
Neuroendocrine/Carcinoid
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 371)
DOI
10.1200/JCO.2021.39.3_suppl.371
Abstract #
371
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Author: Estephany Abou Jokh Casas
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pivotal phase III COMPOSE trial will compare 177Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors.
First Author: Thorvardur Ragnar Halfdanarson
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Predictive role of peritumoral CD3+ infiltration and neutrophil to lymphocyte ratio on overall survial in pateints affected by colorectal liver metastases treated with chemotherapy and surgery.
First Author: Matteo Cimino
Poster
2024 ASCO Breakthrough
Prognostic value and therapeutic response of neutrophil-to-lymphocyte ratio in penile cancer.
First Author: Xingliang Tan